Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BROOKS LAB vs DECIPHER LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BROOKS LAB DECIPHER LABS BROOKS LAB/
DECIPHER LABS
 
P/E (TTM) x 224.6 18.5 1,215.3% View Chart
P/BV x 5.6 0.7 789.7% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 BROOKS LAB   DECIPHER LABS
EQUITY SHARE DATA
    BROOKS LAB
Mar-24
DECIPHER LABS
Mar-24
BROOKS LAB/
DECIPHER LABS
5-Yr Chart
Click to enlarge
High Rs18526 719.0%   
Low Rs5712 475.4%   
Sales per share (Unadj.) Rs30.335.5 85.2%  
Earnings per share (Unadj.) Rs-7.5-1.7 449.8%  
Cash flow per share (Unadj.) Rs-6.8-1.2 560.6%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs25.021.6 115.4%  
Shares outstanding (eoy) m26.2510.10 259.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.00.5 752.6%   
Avg P/E ratio x-16.2-11.4 142.6%  
P/CF ratio (eoy) x-17.8-15.6 114.4%  
Price / Book Value ratio x4.80.9 555.7%  
Dividend payout %00-   
Avg Mkt Cap Rs m3,178191 1,667.3%   
No. of employees `000NANA-   
Total wages/salary Rs m101277 36.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m795359 221.5%  
Other income Rs m114 267.1%   
Total revenues Rs m806363 222.1%   
Gross profit Rs m-181-9 1,921.5%  
Depreciation Rs m185 391.4%   
Interest Rs m82 359.6%   
Profit before tax Rs m-196-12 1,615.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m05 5.6%   
Profit after tax Rs m-196-17 1,169.0%  
Gross profit margin %-22.7-2.6 867.4%  
Effective tax rate %-0.1-38.4 0.3%   
Net profit margin %-24.6-4.7 527.8%  
BALANCE SHEET DATA
Current assets Rs m310247 125.8%   
Current liabilities Rs m230118 195.8%   
Net working cap to sales %10.136.0 28.0%  
Current ratio x1.32.1 64.3%  
Inventory Days Days21056 375.8%  
Debtors Days Days749793 94.4%  
Net fixed assets Rs m59484 707.2%   
Share capital Rs m262101 259.9%   
"Free" reserves Rs m393118 334.5%   
Net worth Rs m656219 300.0%   
Long term debt Rs m00-   
Total assets Rs m904331 273.4%  
Interest coverage x-22.2-4.2 533.4%   
Debt to equity ratio x00-  
Sales to assets ratio x0.91.1 81.0%   
Return on assets %-20.7-4.4 475.9%  
Return on equity %-29.9-7.7 389.7%  
Return on capital %-28.5-4.5 639.3%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m00-   
Fx outflow Rs m00-   
Net fx Rs m00-   
CASH FLOW
From Operations Rs m-9749 -199.4%  
From Investments Rs m2-18 -10.2%  
From Financial Activity Rs m96-12 -822.7%  
Net Cashflow Rs m119 5.4%  

Share Holding

Indian Promoters % 63.6 0.0 -  
Foreign collaborators % 0.0 16.4 -  
Indian inst/Mut Fund % 3.9 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.4 83.6 43.6%  
Shareholders   11,282 31,838 35.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BROOKS LAB With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on BROOKS LAB vs COMBAT DRUGS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

BROOKS LAB vs COMBAT DRUGS Share Price Performance

Period BROOKS LAB COMBAT DRUGS S&P BSE HEALTHCARE
1-Day -1.98% 1.06% 0.11%
1-Month -3.51% -3.67% -3.22%
1-Year 11.16% -11.65% 42.65%
3-Year CAGR 10.87% -23.69% 19.86%
5-Year CAGR 40.67% -10.47% 25.90%

* Compound Annual Growth Rate

Here are more details on the BROOKS LAB share price and the COMBAT DRUGS share price.

Moving on to shareholding structures...

The promoters of BROOKS LAB hold a 63.6% stake in the company. In case of COMBAT DRUGS the stake stands at 16.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of BROOKS LAB and the shareholding pattern of COMBAT DRUGS.

Finally, a word on dividends...

In the most recent financial year, BROOKS LAB paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

COMBAT DRUGS paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of BROOKS LAB, and the dividend history of COMBAT DRUGS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Falls 423 Points | Nifty Ends Near 23,350 | Adani Enterprises Cracks 23% Sensex Today Falls 423 Points | Nifty Ends Near 23,350 | Adani Enterprises Cracks 23%(Closing)

On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.